Court filing: Intel and VLSI Technology agreed to end a patent dispute in Delaware where Intel previously said VLSI had asked for more than $4B in damages
Blake Brittain / Reuters :
Context & Ripple Effects
This filing closes one front in a multi-year campaign by VLSI Technology, which holds patents once owned by NXP Semiconductors, against Intel. The record across three prior $1B+ trials was split: a $2.18B jury verdict against Intel in March 2021, a clean non-infringement win for Intel a month later, and a $948.8M Texas judgment in November 2022 — weeks before this Delaware case, where Intel said VLSI had sought more than $4B, was settled out.
The settlement matters because it removed Intel's largest remaining damages exposure at the time — though not the end of the story: an appeals court later threw out the $2.18B win entirely, sending a second VLSI patent to retrial.
First-order effects
- Intel extinguishes a claimed $4B+ liability in Delaware without a fourth jury verdict, capping its cash cost on this front at the earlier judgments.
- VLSI trades a speculative eight-figure-plus upside in Delaware for certain settlement proceeds, after winning only two of its first three trials against Intel.
Second-order effects
- With the Delaware claim gone, both sides' leverage shifts to the surviving judgments — the $948.8M award and the appealed $2.18B verdict — making appellate outcomes, not new filings, the main pricing mechanism between them.
- A negotiated exit from a $4B ask signals to other holders of legacy NXP-originated patents that full-value recovery against Intel requires settling mid-arc rather than betting on repeated jury trials.
Third-order effects
- If the pattern holds, large-scale chip patent enforcement migrates from serial district-court jury verdicts toward earlier negotiated resolutions, with appeals courts acting as the real arbiter of patent value — as shown when the Federal Circuit later vacated the $2.18B award and forced a retrial on a second patent.
- For Intel, whose litigation docket has run alongside balance-sheet strain, shedding contingent liabilities ahead of capital raises becomes a recurring discipline: settle the tail risk before it compounds.
The trend: Semiconductor patent disputes built on acquired portfolios like VLSI's NXP-derived holdings are converging on mid-litigation settlements, with appellate review increasingly deciding what the patents were worth all along.